Neuroscience and accelerator mass spectrometry.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Mass Spectrometry

• Publication date

  2005-02-01

• Fields of study

  Medicine, Physics, Chemistry

• Identifiers
  DOI 10.1002/JMS.734PMID 15706618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TWENTY YEARS OF ATMOSPHERIC " CO 2 OBSERVATIONS AT SCHAUINSLAND STATION

  2006cited by this paper
• Imaging Calcium Concentration Dynamics in Small Neuronal Compartments

  2004cited by this paper
• High-Throughput Measurement of 41Ca by Accelerator Mass Spectrometry to Quantitate Small Changes in Individual Human Bone Turnover Rates

  2004cited by this paper
• Dementia with Lewy bodies.

  2004cited by this paper
• Accelerator Mass Spectrometry in Protein Analysis

  2004cited by this paper
• Neuropathological spectrum of synucleinopathies

  2003cited by this paper
• Proteomic tools for quantitation by mass spectrometry.

  2003cited by this paper
• Toward a molecular neuropsychiatry of neurodegenerative diseases

  2003cited by this paper
• Alpha-particle energy loss measurement of microgram depositions of biomolecules.

  2003cited by this paper
• A high-throughput method for the conversion of CO2 obtained from biochemical samples to graphite in septa-sealed vials for quantification of 14C via accelerator mass spectrometry.

  2003cited by this paper
• Protein binding of isofluorophate in vivo after coexposure to multiple chemicals.

  2002cited by this paper
• A new accelerator mass spectrometry system for -quantification of biochemical samples

  2002cited by this paper
• Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria.

  2002cited by this paper
• Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer's disease.

  2002cited by this paper
• Dendrite growth increased by visual activity requires NMDA receptor and Rho GTPases

  2002cited by this paper
• Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization.

  2002cited by this paper
• Brain uptake, retention, and efflux of aluminum and manganese.

  2002cited by this paper
• Proteomics goes quantitative: measuring protein abundance.

  2002cited by this paper
• In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane.

  2002cited by this paper
• Spike timing, calcium signals and synaptic plasticity.

  2002cited by this paper
• Attomole quantitation of protein separations with accelerator mass spectrometry

  2001cited by this paper
• Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination.

  2001cited by this paper
• Ca(2+) signaling in dendritic spines.

  2001cited by this paper
• Aluminium toxicokinetics: an updated minireview.

  2001cited by this paper
• Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure.

  2001cited by this paper
• Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats.

  2000cited by this paper
• Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research.

  2000cited by this paper
• [Dementia with Lewy bodies].

  2000cited by this paper
• Isotope-labeled immunoassays without radiation waste.

  2000cited by this paper
• Recent advances in the applications of radioisotopes in drug metabolism, toxicology and pharmacokinetics.

  2000cited by this paper
• Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity.

  1999cited by this paper
• Calcium- and activity-dependent synaptic plasticity.

  1999cited by this paper
• HPLC-accelerator MS measurement of atrazine metabolites in human urine after dermal exposure.

  1999cited by this paper
• Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine.

  1998cited by this paper
• Effects of chronic, low-level organophosphate exposure on delayed recall, discrimination, and spatial learning in monkeys and rats.

  1998cited by this paper
• Twenty Years of Atmospheric 14Co2 Observations At Schauinsland Station, Germany

  1997cited by this paper
• Pyrethroid Decrease in Central Nervous System from Nerve Agent Pretreatment

  1997cited by this paper
• Elements in biological AMS

  1997cited by this paper
• Rapid Production of Graphite Without Contamination for Biomedical AMS

  1992cited by this paper
• Radiocarbon after four decades : an interdisciplinary perspective

  1992cited by this paper
• Radiocarbon in Atmospheric Carbon Dioxide and Methane: Global Distribution and Trends

  1992cited by this paper
• Chronic central nervous system effects of acute organophosphate pesticide intoxication. The Pesticide Health Effects Study Group.

  1991cited by this paper
• Basic Neurochemistry: Molecular, Cellular and Medical Aspects

  1989cited by this paper
• Catalyst and binder effects in the use of filamentous graphite for AMS

  1987cited by this paper
• Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome.

  1987cited by this paper
• Chronology of cholelithiasis. Dating gallstones from atmospheric radiocarbon produced by nuclear bomb explosions.

  1986cited by this paper
• 25 Years of Tropospheric 14C Observations in Central Europe

  1985cited by this paper
• 25 Years of trospheric 14C observations

  1985cited by this paper
• Performance of catalytically condensed carbon for use in accelerator mass spectrometry

  1984cited by this paper
• Time History of Human Gallstones: Application of the Post-Bomb Radiocarbon Signal

  1983cited by this paper
• Bomb 14C as a biological tracer

  1977cited by this paper
• Motor nerve terminal response to edrophonium in delayed DFP neuropathy.

  1975cited by this paper
• Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs.

  1974cited by this paper
• Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs.

  1974cited by this paper
• Further Investigations of the Transfer of Bomb 14C to Man

  1972cited by this paper
• Bomb 14 C in the human population.

  1971cited by this paper
• Bomb 14C in the Human Population

  1971cited by this paper
• Distribution of Radiocarbon from Nuclear Tests

  1965cited by this paper
• Bomb Carbon-14 in Human Beings

  1959cited by this paper
• [Clinical evaluation of DFP (diisopropyl fluorophosphate) in glaucoma].

  1950cited by this paper
• Dendrite growth increased by visual activity requires NMDA receptor and Rho GTPases

  year unknowncited by this paper

• The Development and Application of Tritium-Labeled Compounds in Biomedical Research

  2024cites this paper
• Quantifying exploratory low dose compounds in humans with AMS.

  2011cites this paper
• Accelerator Mass Spectrometry and Positron Emission Tomography in Human Microdosing

  2011cites this paper
• Method for evaluating the potential of C labeled plant polyphenols to cross the blood-brain barrier using accelerator mass spectrometry.

  2010cites this paper
• Accelerator mass spectrometry-enabled studies: current status and future prospects.

  2010cites this paper
• Exploring New Routes for Neuroprotective Drug Development in Traumatic Brain Injury

  2010cites this paper
• Dating the time of birth: A radiocarbon calibration curve for human eye-lens crystallines

  2010cites this paper
• Pharmacokinetics and tissue distribution of 14C-labeled grape polyphenols in the periphery and the central nervous system following oral administration.

  2010cites this paper
• Chapter 25 The Use of Isotopically Labeled Compounds in Drug Discovery

  2009cites this paper
• Pharmaceutical Applications of Accelerator Mass Spectrometry

  2009cites this paper
• Accelerator mass spectrometry.

  2008cites this paper
• Risk assessment of Bundeswehr (German Federal Armed Forces) permethrin-impregnated battle dress uniforms (BDU).

  2008cites this paper
• [Chronic neurological diseases: from the clinical setting to the population clinical setting].

  2007cites this paper